| Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both MA Pfeffer, JJV McMurray, EJ Velazquez, JL Rouleau, L Køber, ... New England Journal of Medicine 349 (20), 1893-1906, 2003 | 3200 | 2003 |
| Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure NF Voelkel, RA Quaife, LA Leinwand, RJ Barst, MD McGoon, ... Circulation 114 (17), 1883-1891, 2006 | 1376 | 2006 |
| Cellular and molecular basis of pulmonary arterial hypertension NW Morrell, S Adnot, SL Archer, J Dupuis, P Lloyd Jones, MR MacLean, ... Journal of the American College of Cardiology 54 (1_Supplement_S), S20-S31, 2009 | 994 | 2009 |
| Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes: the RECIFE (Reduction of Cholesterol in Ischemia and Function of the Endothelium) trial J Dupuis, JC Tardif, P Cernacek, P Théroux Circulation 99 (25), 3227-3233, 1999 | 817 | 1999 |
| Human pulmonary circulation is an important site for both clearance and production of endothelin-1 J Dupuis, DJ Stewart, P Cernacek, G Gosselin Circulation 94 (7), 1578-1584, 1996 | 405 | 1996 |
| Pulmonary clearance of circulating endothelin-1 in dogs in vivo: exclusive role of ETBreceptors J Dupuis, CA Goresky, A Fournier Journal of applied physiology 81 (4), 1510-1515, 1996 | 356 | 1996 |
| Endothelin receptor antagonists in pulmonary arterial hypertension J Dupuis, MM Hoeper European Respiratory Journal 31 (2), 407-415, 2008 | 265 | 2008 |
| Tolerance to intravenous nitroglycerin in patients with congestive heart failure: role of increased intravascular volume, neurohumoral activation and lack of prevention with N … J Dupuis, G Lalonde, R Lemieux, JL Rouleau Journal of the American College of Cardiology 16 (4), 923-931, 1990 | 251 | 1990 |
| Effects of early treatment with statins on short-term clinical outcomes in acute coronary syndromes: a meta-analysis of randomized controlled trials M Briel, GG Schwartz, PL Thompson, JA De Lemos, MA Blazing, ... Jama 295 (17), 2046-2056, 2006 | 246 | 2006 |
| Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non–Q-wave myocardial infarction Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients ... New England Journal of Medicine 338 (21), 1488-1497, 1998 | 230 | 1998 |
| National Heart, Lung, and Blood Institute Working Group on Cellular and Molecular Mechanisms of Right Heart Failure. Right ventricular function and failure: report of a … NF Voelkel, RA Quaife, LA Leinwand, RJ Barst, MD McGoon, ... Circulation 114 (17), 1883-1891, 2006 | 228 | 2006 |
| Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial JC Tardif, N Bouabdallaoui, PL L'allier, D Gaudet, B Shah, MH Pillinger, ... The Lancet Respiratory Medicine 9 (8), 924-932, 2021 | 222 | 2021 |
| 2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology focused update of the guidelines for the use of antiplatelet therapy SR Mehta, KR Bainey, WJ Cantor, M Lordkipanidzé, G Marquis-Gravel, ... Canadian Journal of Cardiology 34 (3), 214-233, 2018 | 171 | 2018 |
| Effectiveness of a Nonselective ETA/B and a Selective ETA Antagonist in Rats With Monocrotaline-Induced Pulmonary Hypertension JF Jasmin, M Lucas, P Cernacek, J Dupuis Circulation 103 (2), 314-318, 2001 | 171 | 2001 |
| Reduced pulmonary clearance of endothelin-1 in pulmonary hypertension J Dupuis, P Cernacek, JC Tardif, DJ Stewart, G Gosselin, I Dyrda, ... American heart journal 135 (4), 614-620, 1998 | 139 | 1998 |
| A pilot study: the noninvasive surface cooling thermoregulatory system for mild hypothermia induction in acute myocardial infarction (the NICAMI Study) HQ Ly, A Denault, J Dupuis, A Vadeboncoeur, F Harel, A Arsenault, ... American heart journal 150 (5), 933. e9-933. e13, 2005 | 123 | 2005 |
| Short-term administration of a cell-permeable caveolin-1 peptide prevents the development of monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy JF Jasmin, I Mercier, J Dupuis, HB Tanowitz, MP Lisanti Circulation 114 (9), 912-920, 2006 | 117 | 2006 |
| Efficacy of colchicine in non-hospitalized patients with COVID-19 JC Tardif, N Bouabdallaoui, PL L’Allier, D Gaudet, B Shah, MH Pillinger, ... Medrxiv, 2021.01. 26.21250494, 2021 | 111 | 2021 |
| Lung remodeling and pulmonary hypertension after myocardial infarction: pathogenic role of reduced caveolin expression JF Jasmin, I Mercier, R Hnasko, MWC Cheung, HB Tanowitz, J Dupuis, ... Cardiovascular Research 63 (4), 747-755, 2004 | 108 | 2004 |
| Inhaled epoprostenol (prostacyclin) and pulmonary hypertension before cardiac surgery M Haché, A Denault, S Bélisle, D Robitaille, P Couture, P Sheridan, ... The Journal of thoracic and cardiovascular surgery 125 (3), 642-649, 2003 | 108 | 2003 |
Rouleau JProfessor of Medicine, Université de MontréalПотвърден имейл адрес: umontreal.ca
